The weight-loss drugs market is set to grow to around Rs 5,000 crore in India by 2030, up from Rs 1,000 crore at present, ...

GLP-1 receptor agonists have gained attention as medications to manage type 2 diabetes and obesity. Drugs such as semaglutide and tirzepatide help regulate blood sugar and reduce appetite, which can ...

Celebs may promote elaborate diets, but don’t forget they have a retinue of staff preparing their multiple juices, brews, and ...

From Coles and Woolworths to fast food chains, a phalanx of thinner and healthier customers is forcing a rethink of what products are going to sell.

People using weight loss injections could experience a range of side effects that affect roughly "one in 10". Medical ...

Performance-enhancing peptides are increasingly popular among fitness enthusiasts and biohackers, despite limited human ...

Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg IV cohorts;Received written FDA Type C meeting minutes ...

Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily ...

Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg ...

ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after ...